Evidence map›Paper›PMID 26820412›Full record

ReviewTransgenic research2016

Advances in genetic engineering of the avian genome: "Realising the promise".

Timothy J Doran, Caitlin A Cooper, Kristie A Jenkins, Mark L V Tizard

Abstract readReview
PubMed Publisher
In one paragraph

Review in Transgenic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Overview of Avian Sex Reversal.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. EffectiveInternational journal of molecular sciences · 2020
    Article
  12. Article
  13. Embryonic Chicken (Comparative medicine · 2019
    Review
  14. Avian Bioreactor Systems: A Review.Molecular biotechnology · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Timothy J DoranAustralian Animal Health Laboratory, CSIRO Health and Biosecurity, Private Bag 24, Geelong, VIC, 3220, Australia. timothy.doran@csiro.au.
Caitlin A CooperAustralian Animal Health Laboratory, CSIRO Health and Biosecurity, Private Bag 24, Geelong, VIC, 3220, Australia.
Kristie A JenkinsAustralian Animal Health Laboratory, CSIRO Health and Biosecurity, Private Bag 24, Geelong, VIC, 3220, Australia.
Mark L V TizardAustralian Animal Health Laboratory, CSIRO Health and Biosecurity, Private Bag 24, Geelong, VIC, 3220, Australia.
Australian Centre for Disease Preparedness · AUCSIRO Health and Biosecurity · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review provides an historic perspective of the key steps from those reported at the 1st Transgenic Animal Research Conference in 1997 through to the very latest developments in avian transgenesis. Eighteen years later, on the occasion of the 10th conference in this series, we have seen breakthrough advances in the use of viral vectors and transposons to transform the germline via the direct manipulation of the chicken embryo, through to the establishment of PGC cultures allowing in vitro modification, expansion into populations to analyse the genetic modifications and then injection of these cells into embryos to create germline chimeras. We have now reached an unprecedented time in the history of chicken transgenic research where we have the technology to introduce precise, targeted modifications into the chicken genome, ranging from; new transgenes that provide improved phenotypes such as increased resilience to economically important diseases; the targeted disruption of immunoglobulin genes and replacement with human sequences to generate transgenic chickens that express "humanised" antibodies for biopharming; and the deletion of specific nucleotides to generate targeted gene knockout chickens for functional genomics. The impact of these advances is set to be realised through applications in chickens, and other bird species as models in scientific research, for novel biotechnology and to protect and improve agricultural productivity.

Indexed as

AnimalsAnimals, Genetically ModifiedBiotechnologyChickensGenetic EngineeringGenomeGerm CellsHumansAvianGenetic engineeringGenome engineeringPoultryTransgenic chicken

Identifiers

PMID26820412
OpenAlexW2292158971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.